Results showed a consistent benefit in both patients with and those without heart failure.
AHA 2015 Complete Coverage
Results from the SPRINT trial suggest that a systolic blood pressure target of 120 mm Hg instead of 140 mm Hg may prevent CV events.
Disclosing genetic risk information resulted in lower LDL cholesterol levels in patients at risk for coronary heart disease.
A decrease was noted in the number of people who score highly on 7 metrics of cardiovascular health defined by the AHA.
Physicians may need to ask young adults about energy drink intake in emergency settings.
Only one-third to one-half of eligible Hispanic patients studied are taking statins or other lipid-lowering therapies.
Mortality rate is higher among women with heart disease after discharge from the hospital.
Obese children as young as age 8 years have signs of heart disease and heart muscle abnormalities.
Results from the Fifty-Fifty trial demonstrated the success of peer support in reducing cardiovascular risk factors.
Many women in the United States do not feel personally connected to the risk of heart disease.
Personalized medications based on a patient's medical and biological profiles may be possible with 3D printing.
Sign Up for Free e-Newsletters
Check out what's trending
Endocrinology Advisor Articles
- Subclinical Hypothyroidism: Controversies in Testing and Treatment
- Favorable Outcomes With Second-Generation Insulin Analogs in Type 2 Diabetes
- Fatigue Management Contributes to Effective Endometriosis Care
- Assessment of Low-Dose Aspirin As Chemoprevention in Type 2 Diabetes
- Treatment With Alemtuzumab May Frequently Induce Thyroid Dysfunction
- Using Latent Class Trajectory Analysis to Determine Glucose Response Curve Patterns
- First CGM System With Implantable Glucose Sensor Approved
- Empagliflozin, Linagliptin Combination Therapy vs Linagliptin Monotherapy for Type 2 Diabetes
- Risk for Below Knee Amputations With Canagliflozin vs Other Antihyperglycemic Agents
- Two Phases of C-Peptide Decline Identified in Type I Diabetes
- Risk for Hypoglycemia During Titration With Insulin Glargine 100 U/mL in T2D
- Trulicity Labeling Updated to Include Data on T2D Patients With CKD
- New Data Support Long-Term Cardiovascular Safety of Linagliptin in T2D
- Peer-Led Education Helps Physicians Save Time With EHRs
- As Immigration Policies Tighten, Physician Shortage Concerns Grow